Trends in lifetime risk and years of potential life lost from diabetes in the United States, 1997-2018
Koyama AK, Cheng YJ, Brinks R, Xie H, Gregg EW, Hoyer A, Pavkov ME, Imperatore G (2022)
PLoS ONE 17(5): e0268805.
Zeitschriftenaufsatz
| Veröffentlicht | Englisch
Download
Es wurden keine Dateien hochgeladen. Nur Publikationsnachweis!
Autor*in
Koyama, Alain K;
Cheng, Yiling J;
Brinks, Ralph;
Xie, Hui;
Gregg, Edward W;
Hoyer, AnnikaUniBi ;
Pavkov, Meda E;
Imperatore, Giuseppina
Abstract / Bemerkung
BACKGROUND: Both incidence and mortality of diagnosed diabetes have decreased over the past decade. However, the impact of these changes on key metrics of diabetes burden-lifetime risk (LR), years of potential life lost (YPLL), and years spent with diabetes-is unknown.; METHODS: We used data from 653,811 adults aged ≥18 years from the National Health Interview Survey, a cross-sectional sample of the civilian non-institutionalized population in the United States. LR, YPLL, and years spent with diabetes were estimated from age 18 to 84 by survey period (1997-1999, 2000-2004, 2005-2009, 2010-2014, 2015-2018). The age-specific incidence of diagnosed diabetes and mortality were estimated using Poisson regression. A multistate difference equation accounting for competing risks was used to model each metric.; RESULTS: LR and years spent with diabetes initially increased then decreased over the most recent time periods. LR for adults at age 20 increased from 31.7% (95% CI: 31.2-32.1%) in 1997-1999 to 40.7% (40.2-41.1%) in 2005-2009, then decreased to 32.8% (32.4-33.2%) in 2015-2018. Both LR and years spent with diabetes were markedly higher among adults of non-Hispanic Black, Hispanic, and other races compared to non-Hispanic Whites. YPLL significantly decreased over the study period, with the estimated YPLL due to diabetes for an adult aged 20 decreasing from 8.9 (8.7-9.1) in 1997-1999 to 6.2 (6.1-6.4) in 2015-2018 (p = 0.02).; CONCLUSION: In the United States, diabetes burden is declining, but disparities by race/ethnicity remain. LR remains high with approximately one-third of adults estimated to develop diabetes during their lifetime.
Erscheinungsjahr
2022
Zeitschriftentitel
PLoS ONE
Band
17
Ausgabe
5
Art.-Nr.
e0268805
ISSN
1932-6203
Page URI
https://pub.uni-bielefeld.de/record/2963688
Zitieren
Koyama AK, Cheng YJ, Brinks R, et al. Trends in lifetime risk and years of potential life lost from diabetes in the United States, 1997-2018. PLoS ONE . 2022;17(5): e0268805.
Koyama, A. K., Cheng, Y. J., Brinks, R., Xie, H., Gregg, E. W., Hoyer, A., Pavkov, M. E., et al. (2022). Trends in lifetime risk and years of potential life lost from diabetes in the United States, 1997-2018. PLoS ONE , 17(5), e0268805. https://doi.org/10.1371/journal.pone.0268805
Koyama, Alain K, Cheng, Yiling J, Brinks, Ralph, Xie, Hui, Gregg, Edward W, Hoyer, Annika, Pavkov, Meda E, and Imperatore, Giuseppina. 2022. “Trends in lifetime risk and years of potential life lost from diabetes in the United States, 1997-2018”. PLoS ONE 17 (5): e0268805.
Koyama, A. K., Cheng, Y. J., Brinks, R., Xie, H., Gregg, E. W., Hoyer, A., Pavkov, M. E., and Imperatore, G. (2022). Trends in lifetime risk and years of potential life lost from diabetes in the United States, 1997-2018. PLoS ONE 17:e0268805.
Koyama, A.K., et al., 2022. Trends in lifetime risk and years of potential life lost from diabetes in the United States, 1997-2018. PLoS ONE , 17(5): e0268805.
A.K. Koyama, et al., “Trends in lifetime risk and years of potential life lost from diabetes in the United States, 1997-2018”, PLoS ONE , vol. 17, 2022, : e0268805.
Koyama, A.K., Cheng, Y.J., Brinks, R., Xie, H., Gregg, E.W., Hoyer, A., Pavkov, M.E., Imperatore, G.: Trends in lifetime risk and years of potential life lost from diabetes in the United States, 1997-2018. PLoS ONE . 17, : e0268805 (2022).
Koyama, Alain K, Cheng, Yiling J, Brinks, Ralph, Xie, Hui, Gregg, Edward W, Hoyer, Annika, Pavkov, Meda E, and Imperatore, Giuseppina. “Trends in lifetime risk and years of potential life lost from diabetes in the United States, 1997-2018”. PLoS ONE 17.5 (2022): e0268805.
Daten bereitgestellt von European Bioinformatics Institute (EBI)
Zitationen in Europe PMC
Daten bereitgestellt von Europe PubMed Central.
References
Daten bereitgestellt von Europe PubMed Central.
Export
Markieren/ Markierung löschen
Markierte Publikationen
Web of Science
Dieser Datensatz im Web of Science®Quellen
PMID: 35609056
PubMed | Europe PMC
Suchen in